Structure’s pill is part of the same class of drugs as Novo Nordisk’s blockbuster diabetes drug Ozempic and weight loss counterpart Wegovy.
The once-daily drug helped overweight or obese participants reduce up to 10 pounds of weight on average after four weeks of treatment, according to a
from the company. Structure said it plans to test its pill in two longer mid-stage trials as a treatment for diabetes and obesity.'s blockbuster diabetes drug Ozempic and weight loss counterpart Wegovy.Those treatments, known as GLP-1s, have soared in popularity this year due to their ability to help patients lose unwanted pounds. GLP-1s mimic a hormone produced in the gut to suppress a person's appetite.
Companies like Structure are trying to capitalize on the booming obesity drug industry, which analysts say could be a
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Structure Therapeutics shares surge after positive results in weight-loss trial, $300 million private placementStructure Therapeutics Inc.’s American depositary receipts jumped more than 90% premarket on Friday after the company announced positive results from an...
Read more »
Alleged Killer of 'Forbes 30 Under 30' CEO Released by Soros DAThe alleged killer of tech CEO Pava LaPere was released by a George Soros-backed district attorney despite a violent history.
Read more »
30 Overlooked 1993 Albums Turning 301993 was a great year for music. Many albums were celebration, but many were not. Here is a list of overlooked 1993 albums
Read more »
Pava LaPere’s murder renews discussion of Forbes 30 under 30 ‘curse’The brutal slaying of Baltimore tech CEO Pava LaPere is sparking fresh fears of a supposed “curse” in making Forbes’ prestigious 30 under 30 list of young business powerbrokers. T…
Read more »
Peloton shares surge 30% on Lululemon partnershipPeloton shares soared 30% in extended trading Wednesday after the company announced a five-year partnership with fellow high-end fitness brand Lululemon.
Read more »
Peloton shares soar 30% on digital content partnership with LululemonPeloton shares spiked Wednesday as the company announced a five-year partnership to develop digital fitness content for Lululemon. The fitness company’s stock soared as much as 30% in extended trading. This is breaking news. Please check back for updates.
Read more »